In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
about
The mycetoma knowledge gap: identification of research prioritiesMadurella mycetomatis is highly susceptible to ravuconazolePhenotypic and molecular characterization of Madurella pseudomycetomatis sp. nov., a novel opportunistic fungus possibly causing black-grain mycetomaFructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis.New species of Madurella, causative agents of black-grain mycetoma.In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafineIn vitro antifungal activity of isavuconazole against Madurella mycetomatisPhylogenetic analysis of the complete mitochondrial genome of Madurella mycetomatis confirms its taxonomic position within the order Sordariales.Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxiRapid susceptibility testing of medically important zygomycetes by XTT assay.Mycetoma medical therapy.In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals.The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agent.A Madurella mycetomatis Grain Model in Galleria mellonella Larvae.Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.Molecular diagnosis and therapeutic experience of subcutaneous Pyrenochaeta romeroi infection: a case report and review of the literature.Mycetoma: An Update.Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents.Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis.Closing the mycetoma knowledge gap.Pleurostomophora ochracea, a novel agent of human eumycetoma with yellow grainsIn vitro interaction of currently used azoles with terbinafine against Madurella mycetomatis.The effect of cinnamaldehyde on the growth and the morphology of Candida albicans.A rapid microplate method for the proliferation assay of fungi and the antifungal susceptibility testing using the colorimetric microbial viability assay.Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma.
P2860
Q27010109-C92ACCCB-B961-45E0-A7EB-BBF3E39BC756Q28539848-5ACE79BB-703E-47E8-BA1D-7F573074601DQ33516201-87B488FF-E29B-4EAD-84EE-43032790BDFAQ33950715-23D544DB-455B-4016-A403-6AC05E89F506Q34113411-6BA2999B-C46E-4E9E-9DB3-4E38DD0E7983Q34160621-24E5DE41-C16E-4191-A807-8797732333AFQ34298778-95E35818-389B-4155-9145-DA7E9FA81D04Q34305638-3FE6BD8C-78E8-487E-BD18-5677444E3AE9Q34406720-BAE831EF-FE7C-4D07-926D-2D10170E6FD0Q34430832-C28CA2CB-4B61-4212-AB1D-ABE52DC8EFE0Q35351362-6163F398-585C-4EA2-9019-F02537D43160Q35551018-C4E9EFEE-40AC-418E-9802-E3814CAE9166Q35576645-E1B340F6-B336-435E-BCAF-03D6873B441FQ35691062-BF3E8ACC-B8CE-4DFB-AAA7-B7061E50E65DQ35819627-547D09D3-7F63-4673-BD48-253676C6641BQ38145356-0F02AD4D-2A61-4DD3-94F8-CEA9BA29F30BQ39392211-16032CC9-7E92-42A2-BF06-86D289F8F19BQ40749902-1BC205CB-2E50-4EA4-8E99-A4D63BF92668Q41989500-5D7BA88C-587D-4D61-B76A-F997378C4F80Q41989548-E2978456-8FFC-498B-AD87-F6251678615CQ42281126-378C8ED7-C089-41AC-9B0D-5680B6212A7BQ43156986-E8D9657E-4420-44A1-B2E7-025C0C00CAD2Q43741455-7D33C77F-09C9-4A93-B256-9BBBAF2A6916Q50700721-9CAB1C50-D437-49D8-B06D-216ED6B4E82EQ52561208-03823670-991C-4D1B-BC79-EF96F18770D8
P2860
In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
In vitro susceptibilities of M ...... azolium hydroxide (XTT) assay.
@en
type
label
In vitro susceptibilities of M ...... azolium hydroxide (XTT) assay.
@en
prefLabel
In vitro susceptibilities of M ...... azolium hydroxide (XTT) assay.
@en
P2093
P2860
P1476
In vitro susceptibilities of M ...... azolium hydroxide (XTT) assay.
@en
P2093
Abdalla O A Ahmed
Ahmed H Fahal
Irma A J M Bakker-Woudenberg
Wendy W J van de Sande
Wim van Vianen
P2860
P304
P356
10.1128/AAC.48.7.2742-2746.2004
P407
P577
2004-07-01T00:00:00Z